Cargando…
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766425/ https://www.ncbi.nlm.nih.gov/pubmed/35069197 http://dx.doi.org/10.3389/fphar.2021.772435 |
_version_ | 1784634527820283904 |
---|---|
author | She, Jianglian Gu, Tanwei Pang, Xiaoyan Liu, Yonghong Tang, Lan Zhou, Xuefeng |
author_facet | She, Jianglian Gu, Tanwei Pang, Xiaoyan Liu, Yonghong Tang, Lan Zhou, Xuefeng |
author_sort | She, Jianglian |
collection | PubMed |
description | Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndrome-related diseases. In recent years, natural products targeting LXRs and FXR have received remarkable interests as a valuable source of novel ligands encompassing diverse chemical structures and bioactive properties. This review aims to survey natural products, originating from terrestrial plants and microorganisms, marine organisms, and marine-derived microorganisms, which could influence LXRs and FXR. In the recent two decades (2000–2020), 261 natural products were discovered from natural resources such as LXRs/FXR modulators, 109 agonists and 38 antagonists targeting LXRs, and 72 agonists and 55 antagonists targeting FXR. The docking evaluation of desired natural products targeted LXRs/FXR is finally discussed. This comprehensive overview will provide a reference for future study of novel LXRs and FXR agonists and antagonists to target human diseases, and attract an increasing number of professional scholars majoring in pharmacy and biology with more in-depth discussion. |
format | Online Article Text |
id | pubmed-8766425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87664252022-01-20 Natural Products Targeting Liver X Receptors or Farnesoid X Receptor She, Jianglian Gu, Tanwei Pang, Xiaoyan Liu, Yonghong Tang, Lan Zhou, Xuefeng Front Pharmacol Pharmacology Nuclear receptors (NRs) are a superfamily of transcription factors induced by ligands and also function as integrators of hormonal and nutritional signals. Among NRs, the liver X receptors (LXRs) and farnesoid X receptor (FXR) have been of significance as targets for the treatment of metabolic syndrome-related diseases. In recent years, natural products targeting LXRs and FXR have received remarkable interests as a valuable source of novel ligands encompassing diverse chemical structures and bioactive properties. This review aims to survey natural products, originating from terrestrial plants and microorganisms, marine organisms, and marine-derived microorganisms, which could influence LXRs and FXR. In the recent two decades (2000–2020), 261 natural products were discovered from natural resources such as LXRs/FXR modulators, 109 agonists and 38 antagonists targeting LXRs, and 72 agonists and 55 antagonists targeting FXR. The docking evaluation of desired natural products targeted LXRs/FXR is finally discussed. This comprehensive overview will provide a reference for future study of novel LXRs and FXR agonists and antagonists to target human diseases, and attract an increasing number of professional scholars majoring in pharmacy and biology with more in-depth discussion. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8766425/ /pubmed/35069197 http://dx.doi.org/10.3389/fphar.2021.772435 Text en Copyright © 2022 She, Gu, Pang, Liu, Tang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology She, Jianglian Gu, Tanwei Pang, Xiaoyan Liu, Yonghong Tang, Lan Zhou, Xuefeng Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title | Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title_full | Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title_fullStr | Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title_full_unstemmed | Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title_short | Natural Products Targeting Liver X Receptors or Farnesoid X Receptor |
title_sort | natural products targeting liver x receptors or farnesoid x receptor |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766425/ https://www.ncbi.nlm.nih.gov/pubmed/35069197 http://dx.doi.org/10.3389/fphar.2021.772435 |
work_keys_str_mv | AT shejianglian naturalproductstargetingliverxreceptorsorfarnesoidxreceptor AT gutanwei naturalproductstargetingliverxreceptorsorfarnesoidxreceptor AT pangxiaoyan naturalproductstargetingliverxreceptorsorfarnesoidxreceptor AT liuyonghong naturalproductstargetingliverxreceptorsorfarnesoidxreceptor AT tanglan naturalproductstargetingliverxreceptorsorfarnesoidxreceptor AT zhouxuefeng naturalproductstargetingliverxreceptorsorfarnesoidxreceptor |